| For: | Mukherjee A, Biswas A, Das SK. Gut dysfunction in Parkinson's disease. World J Gastroenterol 2016; 22(25): 5742-5752 [PMID: 27433087 DOI: 10.3748/wjg.v22.i25.5742] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i25/5742.htm |
| Number | Citing Articles |
| 1 |
Sangeetha Pabolu, Anwar Dudekula, C. S. Pitchumoni. Geriatric Gastroenterology. 2021; doi: 10.1007/978-3-319-90761-1_86-1
|
| 2 |
Zorisadday Gonzalez, Richard W. McCallum. Gastroparesis. 2021; doi: 10.1016/B978-0-12-818586-5.00020-X
|
| 3 |
Pedro Melo Barbosa, Egberto Reis Barbosa. The Gut Brain-Axis in Neurological Diseases. International Journal of Cardiovascular Sciences 2020; doi: 10.36660/ijcs.20200039
|
| 4 |
Vicky Queen. Advances in Parkinson's disease. British Journal of Neuroscience Nursing 2017; 13(2) doi: 10.12968/bjnn.2017.13.2.94
|
| 5 |
Inga Claus, Carsten Buhmann, Alessandra Fanciulli, Stephan Klebe, Franz Marxreiter, Patrick Süß, David Weise, Tobias Warnecke. Dysphagia and gastrointestinal disorders in Parkinson’s disease: towards a diagnostic standard operating procedure for the interprofessional neurological outpatient care team. Journal of Neural Transmission 2026; doi: 10.1007/s00702-026-03195-z
|
| 6 |
Sephira Ryman, Andrei A. Vakhtin, Sarah Pirio Richardson, Henry C. Lin. Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases. Journal of Neurology 2023; 270(2) doi: 10.1007/s00415-022-11461-9
|
| 7 |
Daniel M. Virga, Jessica Capps, Bhupinder P. S. Vohra. Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity. Neurochemical Research 2018; 43(12) doi: 10.1007/s11064-018-2649-x
|
| 8 |
Quentin Damiens, Victor Mille, Justin Faure, Eric Toussirot, Marie-Blanche Valnet-Rabier, Matthieu Béreau. Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment. Journal of Parkinson’s Disease 2026; 16(5) doi: 10.1177/1877718X261432743
|
| 9 |
Julia Paik. Levodopa Inhalation Powder: A Review in Parkinson’s Disease. Drugs 2020; 80(8) doi: 10.1007/s40265-020-01307-x
|
| 10 |
Sheng Song, Dezhen Tu, Chengbo Meng, Jie Liu, Belinda Wilson, Qingshan Wang, Yen-Yu Ian Shih, Hui-Ming Gao, Jau-Shyong Hong. Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1083513
|
| 11 |
Wen-Xiang Duan, Fen Wang, Jun-Yi Liu, Chun-Feng Liu. Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic. Neuroscience Bulletin 2024; 40(4) doi: 10.1007/s12264-023-01123-9
|
| 12 |
Xiaoling Qin, Xue Li, Zai’e Xin, Zaili Li. Gastrointestinal Dysfunction in Chinese Patients with Parkinson’s Disease. Parkinson's Disease 2019; 2019 doi: 10.1155/2019/3897315
|
| 13 |
Daniele Urso, K. Ray Chaudhuri, Mubasher A. Qamar, Peter Jenner. Improving the Delivery of Levodopa in Parkinson’s Disease: A Review of Approved and Emerging Therapies. CNS Drugs 2020; 34(11) doi: 10.1007/s40263-020-00769-7
|
| 14 |
Karol Sadowski, Weronika Zając, Łukasz Milanowski, Dariusz Koziorowski, Monika Figura. Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson’s Disease: A Review of Inflammatory Markers and Potential Effects. International Journal of Molecular Sciences 2024; 25(14) doi: 10.3390/ijms25147741
|
| 15 |
Arun T Nair, Vadivelan Ramachandran, Nanjan M Joghee, Shanish Antony, Gopalakrishnan Ramalingam. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. Journal of Neurogastroenterology and Motility 2018; 24(1) doi: 10.5056/jnm17105
|
| 16 |
Sooyoung Park, Kiyeon Kim, Deokhyun Lee, TaeHee Kim, Yun Joong Kim, Seok Jong Chung, JuHee Lee. Non-Pharmacological Constipation Management in People With Neurodegenerative Disease: A Scoping Review. Western Journal of Nursing Research 2026; 48(9) doi: 10.1177/01939459261451721
|
| 17 |
Lin Shen, Zhaoqin Wang, Rude Huang, Luyi Wu, Yan Huang, Qin Qi, Rui Zhong, Yiyi Chen, Lingjie Li, Huangan Wu, Talha Bin Emran. Electroacupuncture Modulates 5-HT4R-Mediated cAMP/PKA Signaling to Improve Intestinal Motility Disorders in a Thy1-αSyn Parkinson’s Mouse Model. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/8659462
|
| 18 |
Ankit Srivastava, Arti Kataria, Dharmendra Kumar Yadav, Ihn Han, Eun-Ha Choi. Human-Gut Microbiome. 2022; doi: 10.1016/B978-0-323-91313-3.00003-9
|
| 19 |
Andrew Su, Rita Gandhy, Carrolee Barlow, George Triadafilopoulos. Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation. BMJ Open Gastroenterology 2016; 3(1) doi: 10.1136/bmjgast-2016-000118
|
| 20 |
Maria Luísa Cordeiro Santos, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Mariana Miranda Sampaio, Hanna Santos Marques, Natália Oliveira e Silva, Dulciene Maria de Magalhães Queiroz, Fabrício Freire de Melo. <i>Helicobacter pylori</i> infection: Beyond gastric manifestations. World Journal of Gastroenterology 2020; 26(28): 4076-4093 doi: 10.3748/wjg.v26.i28.4076
|
| 21 |
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare. The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease. Cellular and Molecular Neurobiology 2022; 42(2) doi: 10.1007/s10571-021-01066-7
|
| 22 |
Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, Wei Wu, Mengyu Lai, Xixi Zhang, Jie Li, Zhiling Guan, Huafen Zhao, Wen Li, Hongli Gao, Xiangmei Zhou, Lifeng Yang. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.01155
|
| 23 |
Qiuxiang Huang, Honghao Xu, Yong Luo, Jie Zhou, Mengjia Li, Yujia Li, Qingping Xue, Zichen Wang, Zhuochi Zou, Haroona Bashir, Xianwei Zou. A study on predicting malnutrition risk in Parkinson’s disease patients using a nomogram model. Clinical Parkinsonism & Related Disorders 2025; 13 doi: 10.1016/j.prdoa.2025.100403
|
| 24 |
Shouqi Wang, Feng Zhou, Xianbao Fang, Huanhuan Zhang, Wenhong Yang, Lu Xia, Yunyun Chen, Jie Tan, Ying Wu. Evidence-based summary of the prevention and management of constipation in patients with Parkinson’s disease. Geriatric Nursing 2025; 66 doi: 10.1016/j.gerinurse.2025.103600
|
| 25 |
Milan Beckers, Andrew J. Lees, John G. Nutt, Bastiaan R. Bloem. Turning Back the Clock in Parkinson’s Disease: Practical Recommendations for Managing Diurnal Symptom Worsening. Journal of Parkinson's Disease 2021; 11(3) doi: 10.3233/JPD-212711
|
| 26 |
Stuart H. Isaacson, Fernando L. Pagan, Mark F. Lew, Rajesh Pahwa. Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?. Clinical Parkinsonism & Related Disorders 2022; 7 doi: 10.1016/j.prdoa.2022.100161
|
| 27 |
Sumel Ashique, Sourav Mohanto, Mohammed Gulzar Ahmed, Neeraj Mishra, Ashish Garg, Dinesh Kumar Chellappan, Timothy Omara, Shabnoor Iqbal, Ivan Kahwa. RETRACTED: Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 2024; 10(13) doi: 10.1016/j.heliyon.2024.e34092
|
| 28 |
Milan Beckers, Bastiaan R. Bloem, Marcel M. Verbeek. Mechanisms of peripheral levodopa resistance in Parkinson’s disease. npj Parkinson's Disease 2022; 8(1) doi: 10.1038/s41531-022-00321-y
|
| 29 |
Zihao Lin, Yangdanyu Li, Yuning Liu, Bo Yang, Peixiao Yin, Chenyang Guan, Yating Fang, Liying Yang, Kun Zan, Guiyun Cui, Lu Yu, Xiaojie Wang, Chuanying Xu. Alterations in gut microbiota and plasma metabolites: a multi-omics study of mild cognitive impairment in Parkinson’s disease. Frontiers in Neuroscience 2025; 19 doi: 10.3389/fnins.2025.1667331
|
| 30 |
. 2017; doi: 10.70675/f0642fa8z5c78z4bdfza412z2dea91f47891
|
| 31 |
Wenxia Zheng, Rongni He, Zhenxing Yan, Yaowei Huang, Wei Huang, Zhuoyi Cai, Yuying Su, Siqin Liu, Yiting Deng, Qing Wang, Huifang Xie. Regulation of immune-driven pathogenesis in Parkinson’s disease by gut microbiota. Brain, Behavior, and Immunity 2020; 87 doi: 10.1016/j.bbi.2020.01.009
|
| 32 |
Bang-rong Wei, Yu-jia Zhao, Yu-feng Cheng, Chun Huang, Feng Zhang. Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing 2024; 21(1) doi: 10.1186/s12979-023-00404-1
|
| 33 |
Andrew Su, Rita Gandhy, Carrolee Barlow, George Triadafilopoulos. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms. BMJ Open Gastroenterology 2017; 4(1) doi: 10.1136/bmjgast-2017-000132
|
| 34 |
Ana Beatriz Ramalho Leite Silva, Roger Wilson Gonçalves de Oliveira, Guilherme Pinheiro Diógenes, Marina Feitosa de Castro Aguiar, Camilla Costa Sallem, Micael Porto Portela Lima, Luciano Barroso de Albuquerque Filho, Sara Diógenes Peixoto de Medeiros, Lucas Lopes Penido de Mendonça, Paulo Cesar de Santiago Filho, Diogo Pasquali Nones, Pamella Mendes Martiniano da Silva Cardoso, Michelle Zonkowski Ribas, Stéfani Lara Galvão, Gabriel Felipe Gomes, Amanda Rebouças Bezerra de Menezes, Nayla Lima dos Santos, Victor Monteiro Mororó, Fairane Sousa Duarte, Júlio César Claudino dos Santos. Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art. Ageing Research Reviews 2023; 84 doi: 10.1016/j.arr.2022.101834
|
| 35 |
Nikolaos Kamperidis, Jeremy Nightingale. Neurological disorders and small bowel dysmotility. Current Opinion in Gastroenterology 2022; 38(3) doi: 10.1097/MOG.0000000000000836
|
| 36 |
Pengfei Fu, Meng Gao, Ken Kin Lam Yung. Association of Intestinal Disorders with Parkinson’s Disease and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. ACS Chemical Neuroscience 2020; 11(3) doi: 10.1021/acschemneuro.9b00607
|
| 37 |
Yiying Huang, Jinchi Liao, Xu Liu, Yunxiao Zhong, Xiaodong Cai, Ling Long. Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.615075
|
| 38 |
Jana Harsanyiova, Tomas Buday, Alzbeta Kralova Trancikova. Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00626
|
| 39 |
Zhigao Sun, Xin Su, Xiaoqian Zhao, Yao Yao, Yali Zhao, Pei Zhang, Zhirui Li, Shihui Fu. Associations between constipation, overeating, and depression: A survey of Chinese oldest-old and centenarians. Heliyon 2022; 8(12) doi: 10.1016/j.heliyon.2022.e12432
|
| 40 |
Wen Tan, Qinjun Zhang, Zhijian Dong, Yubin Yan, Yukun Fu, Xuebo Liu, Beita Zhao, Xiang Duan. Phosphatidylcholine Ameliorates LPS-Induced Systemic Inflammation and Cognitive Impairments via Mediating the Gut–Brain Axis Balance. Journal of Agricultural and Food Chemistry 2020; 68(50) doi: 10.1021/acs.jafc.0c06383
|
| 41 |
Shane Shahrestani, Julian Gendreau, Ali R. Tafreshi, Nolan J. Brown, Khashayar Dashtipour. High rates of blood transfusion associated with Parkinson’s disease. Neurological Sciences 2022; 43(8) doi: 10.1007/s10072-022-06097-6
|
| 42 |
Marthinus Janse van Vuuren, Theodore Albertus Nell, Jonathan Ambrose Carr, Douglas B. Kell, Etheresia Pretorius. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease. Biomolecules 2020; 11(1) doi: 10.3390/biom11010030
|
| 43 |
T. Warnecke, K-H. Schäfer, I. Claus, K. Del Tredici, W. H. Jost. Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management. npj Parkinson's Disease 2022; 8(1) doi: 10.1038/s41531-022-00295-x
|
| 44 |
Lingyu Wu, Liwen Chu, Hongdou Cao, Qi Tian, Hua Gao, Jinghong Huo, Qinghan Gao. Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial. Food Bioscience 2024; 57 doi: 10.1016/j.fbio.2023.103548
|
| 45 |
Rafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, Gemma Navarro, Eva Martínez-Pinilla. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease. Frontiers in Aging Neuroscience 2020; 12 doi: 10.3389/fnagi.2020.00012
|
| 46 |
Kathleen Shannon, Pieter Vanden Berghe. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell and Tissue Research 2018; 373(1) doi: 10.1007/s00441-018-2856-4
|
| 47 |
Youngsun Lee, Ji Su Kang, On-Ju Ham, Mi-Young Son, Mi-Ok Lee. Gut metabolite trimethylamine N-oxide induces aging-associated phenotype of midbrain organoids for the induced pluripotent stem cell-based modeling of late-onset disease. Frontiers in Aging Neuroscience 2022; 14 doi: 10.3389/fnagi.2022.925227
|
| 48 |
Abass Olawale Omotosho, Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Sodiq Inaolaji Yusuff, Muritala AbdulKadir, Abdulbasit Opeyemi Muili, Oluwaseyi Muyiwa Egbewande, Rashidat Onyinoyi Yusuf, Zaccheaus Oluwaseun Faniran, Abdullateef Opeyemi Afolabi, Mona Said El‐Sherbini. Parkinson's disease: Are gut microbes involved?. Brain and Behavior 2023; 13(8) doi: 10.1002/brb3.3130
|
| 49 |
Ronald F. Pfeiffer, Stuart H. Isaacson, Rajesh Pahwa. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Parkinsonism & Related Disorders 2020; 76 doi: 10.1016/j.parkreldis.2020.05.001
|
| 50 |
Peter A. LeWitt, Fabrizio Stocchi, David Arkadir, Yoseph Caraco, Liat Adar, Itay Perlstein, Ryan Case, Nir Giladi. The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program. Frontiers in Neurology 2022; 13 doi: 10.3389/fneur.2022.1036068
|
| 51 |
Eamonn M. M. Quigley, Vineet Gudsoorkar. Geriatric Gastroenterology. 2021; doi: 10.1007/978-3-030-30192-7_64
|
| 52 |
Adil Ghafoor, Sahaana Sundar, Tennekoon Karunaratne, Satish S.C. Rao, Amol Sharma. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; doi: 10.1016/B978-0-443-13911-6.00028-1
|
| 53 |
Robin Fackrell, Camille B Carroll, Donald G Grosset, Biju Mohamed, Prashanth Reddy, Miriam Parry, Kallol Ray Chaudhuri, Tom Foltynie. Noninvasive Options for ‘Wearing-off’ in Parkinson’s Disease: A Clinical Consensus From a Panel of Uk Parkinson’s Disease Specialists. Neurodegenerative Disease Management 2018; 8(5) doi: 10.2217/nmt-2018-0020
|
| 54 |
Saam Dilmaghani, Jessica Atieh, Lehar Khanna, Emily A. Hosfield, Michael Camilleri, David A. Katzka. Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson’s disease. Neurogastroenterology & Motility 2022; 34(6) doi: 10.1111/nmo.14280
|
| 55 |
Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar. Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?. Advances in Parkinson's Disease 2017; 6(01) doi: 10.4236/apd.2017.61001
|
| 56 |
Fan Zhang, Liya Yue, Xing Fang, Gengchao Wang, Cuidan Li, Xiaodong Sun, Xinmiao Jia, Jingjing Yang, Jinhui Song, Yu Zhang, Chongye Guo, Guannan Ma, Ming Sang, Fei Chen, Puqing Wang. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. Parkinsonism & Related Disorders 2020; 81 doi: 10.1016/j.parkreldis.2020.10.034
|
| 57 |
Jonathan Timpka, Per Odin. Autonomic Dysfunction in Parkinson's Disease. International Review of Movement Disorders 2021; 1 doi: 10.1016/bs.irmvd.2021.07.004
|
| 58 |
Katayoun Khoshbin, Anhar Hassan, Michael Camilleri. Cohort Study in Parkinsonism. Neurology Clinical Practice 2021; 11(4) doi: 10.1212/CPJ.0000000000001003
|
| 59 |
A.A. Pilipovich, O.V. Vorob’eva, S.A. Makarov, A.V. Kuchuk. Lower gastrointestinal dysfunction in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry 2023; 123(12) doi: 10.17116/jnevro202312312142
|
| 60 |
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim. Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective. Expert Review of Neurotherapeutics 2017; 17(7) doi: 10.1080/14737175.2017.1336087
|
| 61 |
Xin Zhou, Bowen Li, Mingming Guo, Wenchang Peng, Deping Wang, Qinglu Guo, Shuchao Wang, Dong Ming, Bin Zheng. Microneedle patch based on molecular motor as a spatio-temporal controllable dosing strategy of L-DOPA for Parkinson’s disease. Chemical Engineering Journal 2022; 427 doi: 10.1016/j.cej.2021.131555
|
| 62 |
Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease. Current Neuropharmacology 2020; 19(2) doi: 10.2174/1570159X18666200606233050
|
| 63 |
Tino Prell, Caroline Perner. Disease Specific Aspects of Malnutrition in Neurogeriatric Patients. Frontiers in Aging Neuroscience 2018; 10 doi: 10.3389/fnagi.2018.00080
|
| 64 |
Jessica Atieh, Michael Camilleri. Reduced gastric accommodation in patients with Parkinson’s disease: A case series. Neurogastroenterology & Motility 2021; 33(6) doi: 10.1111/nmo.14143
|
| 65 |
Jin Gyu Choi, Eugene Huh, Namkwon Kim, Dong-Hyun Kim, Myung Sook Oh, David I. Finkelstein. High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLOS ONE 2019; 14(8) doi: 10.1371/journal.pone.0217194
|
| 66 |
Yinghui Li, Yumei Liu, Chuanning Du, Jun Wang. Body mass index in patients with Parkinson’s disease: a systematic review. Journal of Neurophysiology 2024; 131(2) doi: 10.1152/jn.00363.2023
|
| 67 |
Narges Dargahi, John Matsoukas, Vasso Apostolopoulos. Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice. Brain Sciences 2020; 10(2) doi: 10.3390/brainsci10020126
|
| 68 |
Sangeetha Pabolu, Anwar Dudekula, C. S. Pitchumoni. Geriatric Gastroenterology. 2021; doi: 10.1007/978-3-030-30192-7_86
|
| 69 |
Devina Chetty, Shameemah Abrahams, Riaan van Coller, Jonathan Carr, Colin Kenyon, Soraya Bardien. Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment. European Journal of Neuroscience 2021; 54(2) doi: 10.1111/ejn.15324
|
| 70 |
Rafael Franco, Berta Casanovas, Jordi Camps, Gemma Navarro, Eva Martínez-Pinilla. Antioxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Current Issues in Molecular Biology 2021; 43(2) doi: 10.3390/cimb43020047
|
| 71 |
Hairong Peng, Shui Yu, Yukai Zhang, Yanqing Yin, Jiawei Zhou. Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration. Neuroscience Bulletin 2022; 38(8) doi: 10.1007/s12264-022-00848-3
|
| 72 |
Ines Tchienga, Brittany Heavens. Mind-Body Practices in Healthcare. 2025; doi: 10.5772/intechopen.1012409
|
| 73 |
Mengting Luan, Jianing Jin, Ying Wang, Xiaoyuan Li, Anmu Xie. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neuroscience Letters 2022; 775 doi: 10.1016/j.neulet.2022.136547
|
| 74 |
Zahari Vinarov, Mohammad Abdallah, José A.G. Agundez, Karel Allegaert, Abdul W. Basit, Marlies Braeckmans, Jens Ceulemans, Maura Corsetti, Brendan T. Griffin, Michael Grimm, Daniel Keszthelyi, Mirko Koziolek, Christine M. Madla, Christophe Matthys, Laura E. McCoubrey, Amitava Mitra, Christos Reppas, Jef Stappaerts, Nele Steenackers, Natalie L. Trevaskis, Tim Vanuytsel, Maria Vertzoni, Werner Weitschies, Clive Wilson, Patrick Augustijns. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. European Journal of Pharmaceutical Sciences 2021; 162 doi: 10.1016/j.ejps.2021.105812
|
| 75 |
Fang Chi, Kun Chen, Yue Yin, Janetta R Hakovirta, Per E J Saris. From dysbiosis to dysfunction: specific gut microbes and metabolites in the pathogenesis of Parkinson’s disease. Sustainable Microbiology 2026; 3(1) doi: 10.1093/sumbio/qvag002
|
| 76 |
Yunbo Zhu, Shuo Wang, Shuang Zhao, Yujia Zeng, Jing Li, Pingyue Wang, Zhijie Dou, Tianjun Wang. Taurine modulates gut microbiota and attenuates inflammation in a rotenone-induced mouse model of Parkinson's disease. NeuroToxicology 2026; 113 doi: 10.1016/j.neuro.2026.103401
|
| 77 |
Yassamine Ouerdane, Mohamed Y. Hassaballah, Abdalrazeq Nagah, Tarek M. Ibrahim, Hosny A. H. Mohamed, Areej El-Baz, Mohamed S. Attia. Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications. Pharmaceuticals 2022; 15(1) doi: 10.3390/ph15010076
|
| 78 |
Eamonn M. M. Quigley, Vineet Gudsoorkar. Geriatric Gastroenterology. 2020; doi: 10.1007/978-3-319-90761-1_64-1
|
| 79 |
Natalia Molinero, Alejandro Antón-Fernández, Félix Hernández, Jesús Ávila, Begoña Bartolomé, M. Victoria Moreno-Arribas. Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration. Neuroscience 2023; 518 doi: 10.1016/j.neuroscience.2023.02.014
|
| 80 |
Lívia H. Morais, Daniela B. Hara, Maíra A. Bicca, Anicleto Poli, Reinaldo N. Takahashi. Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson’s disease. Behavioural Pharmacology 2018; 29(2 and 3) doi: 10.1097/FBP.0000000000000389
|
| 81 |
Paolo Solari, Nicholas Rivelli, Francescaelena De Rose, Lorenzo Picciau, Ludovico Murru, John G. Stoffolano, Anna Liscia, Erik C. Johnson. Opposite effects of 5-HT/AKH and octopamine on the crop contractions in adult Drosophila melanogaster: Evidence of a double brain-gut serotonergic circuitry. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0174172
|
| 82 |
Sania Ansari, Ketan J. Purohit, Ajay B. Shelke, Mahek Shah, Innocent Adamson Nkhoma, Archana M. Navale, Rutika Wakchaure. Microbiota-driven mechanisms in multisystem diseases: integrative evidence across cardiovascular, metabolic, neurological and autoimmune disorders. Antonie van Leeuwenhoek 2026; 119(5) doi: 10.1007/s10482-026-02296-9
|
| 83 |
Ryuji Sakakibara, Hirokazu Doi, Shin Fukudo. Lewy body constipation. Journal of the Anus, Rectum and Colon 2019; 3(1) doi: 10.23922/jarc.2018-022
|
| 84 |
Flaminia Campo, Raffaella Carletti, Massimo Fusconi, Clelia Pellicano, Francesco E. Pontieri, Cira R. Di Gioia, Marco de Vincentiis. Alpha-synuclein in salivary gland as biomarker for Parkinson’s disease. Reviews in the Neurosciences 2019; 30(5) doi: 10.1515/revneuro-2018-0064
|
| 85 |
Han-Lin Chiang, Chin-Hsien Lin. Management of Gastrointestinal Symptoms in Parkinson’s Disease. Journal of Central Nervous System Disease 2025; 17 doi: 10.1177/11795735251370014
|
| 86 |
Michal Lubomski, Ai Huey Tan, Shen-Yang Lim, Andrew J. Holmes, Ryan L. Davis, Carolyn M. Sue. Parkinson’s disease and the gastrointestinal microbiome. Journal of Neurology 2020; 267(9) doi: 10.1007/s00415-019-09320-1
|
| 87 |
Marcos E. Franchello, Juan José Paz. Hospitalización en los pacientes con enfermedad de Parkinson. Revista Médica Clínica Las Condes 2025; 36(3) doi: 10.1016/j.rmclc.2025.06.005
|
| 88 |
Parisa Gazerani. Probiotics for Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174121
|
| 89 |
Dingsheng Wen, Xiangyue Wang, Yanping He, Xiaoqing Hao, Weihua Huang, Honghao Zhou, Wei Zhang, Xiong Li. Pharmacomicrobiomics: Exploring the role of gut microbiota in type 2 diabetes and antidiabetic drug mechanisms. Nutrition, Metabolism and Cardiovascular Diseases 2026; 36(2) doi: 10.1016/j.numecd.2025.104379
|
| 90 |
Jolien Schol, Lucas Wauters, Ram Dickman, Vasile Drug, Agata Mulak, Jordi Serra, Paul Enck, Jan Tack. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United European Gastroenterology Journal 2021; 9(3) doi: 10.1002/ueg2.12060
|
| 91 |
Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao. Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease. Current Neurovascular Research 2019; 16(3) doi: 10.2174/1567202616666190618170103
|
| 92 |
Anna Sauerbier, Ilaria Cova, Miguel Rosa-Grilo, Raquel N. Taddei, Laurie K. Mischley, K. Ray Chaudhuri. Parkinson's Disease. International Review of Neurobiology 2017; 132 doi: 10.1016/bs.irn.2017.03.002
|
| 93 |
Kerstin Thriene, Karin B. Michels. Human Gut Microbiota Plasticity throughout the Life Course. International Journal of Environmental Research and Public Health 2023; 20(2) doi: 10.3390/ijerph20021463
|
| 94 |
Mayela Rodríguez-Violante, Rosalía Zerón-Martínez, Amin Cervantes-Arriaga, Teresa Corona. Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms. Archives of Medical Research 2017; 48(3) doi: 10.1016/j.arcmed.2017.08.005
|
| 95 |
Ke An, Yi Qu, Jingyi Li, Danlei Wang, Zhijuan Mao, Zheng Xue. Associations of diet-derived short chain fatty acids with Parkinson’s disease: a systematic review and meta-analysis. Nutritional Neuroscience 2026; 29(2) doi: 10.1080/1028415X.2025.2558119
|
| 96 |
. 2024; doi: 10.70675/39506037z825cz4e39z88b4zc28c728d0514
|
| 97 |
Xinrong Liu, Shuya Liu, Yong Tang, Zhengjia Pu, Hong Xiao, Jieying Gao, Qi Yin, Yan Jia, Qunhua Bai. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease. Neurochemical Research 2021; 46(6) doi: 10.1007/s11064-021-03293-2
|
| 98 |
Wen-Shin Song, Tai-Ho Hung, Shing-Hwa Liu, Yin-Ting Zheng, Hsin-Mei Lin, Feng-Yi Yang. Neuroprotection by Abdominal Ultrasound in Lipopolysaccharide-Induced Systemic Inflammation. International Journal of Molecular Sciences 2023; 24(11) doi: 10.3390/ijms24119329
|
| 99 |
Hilmar P. Sigurdsson, Rachael Raw, Heather Hunter, Mark R. Baker, John-Paul Taylor, Lynn Rochester, Alison J. Yarnall. Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects. Expert Review of Medical Devices 2021; 18(10) doi: 10.1080/17434440.2021.1969913
|
| 100 |
John-Paul Taylor, Ian G McKeith, David J Burn, Brad F Boeve, Daniel Weintraub, Claire Bamford, Louise M Allan, Alan J Thomas, John T O'Brien. New evidence on the management of Lewy body dementia. The Lancet Neurology 2020; 19(2) doi: 10.1016/S1474-4422(19)30153-X
|
| 101 |
Alexandre Demailly, Caroline Moreau, David Devos. Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics. Journal of Parkinson’s Disease 2024; 14(5) doi: 10.3233/JPD-230372
|
| 102 |
Shivani Ghaisas, Monica R. Langley, Bharathi N. Palanisamy, Somak Dutta, Kirthi Narayanaswamy, Paul J. Plummer, Souvarish Sarkar, Muhammet Ay, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson’s disease. NeuroToxicology 2019; 75 doi: 10.1016/j.neuro.2019.09.004
|
| 103 |
Aiqun Lin, Wenxia Zheng, Yan He, Wenli Tang, Xiaobo Wei, Rongni He, Wei Huang, Yuying Su, Yaowei Huang, Hongwei Zhou, Huifang Xie. Gut microbiota in patients with Parkinson's disease in southern China. Parkinsonism & Related Disorders 2018; 53 doi: 10.1016/j.parkreldis.2018.05.007
|
| 104 |
Sonam M. Gandhi, Ashu Tyagi, Satyam Shukla, Nitin G. Haswani, Shadma Wahab, Saad Ali Alshehri, Devesh U. Kapoor. Microneedle-mediated drug delivery for Parkinson’s disease: advances, challenges, and future perspectives. Journal of Biomaterials Science, Polymer Edition 2026; doi: 10.1080/09205063.2026.2683530
|
| 105 |
Mengxia Wang, Yan Ma, Bao Zeng, Wenhao Yang, Cuihong Huang, Benqin Tang. Influence of the Gut Microbiota, Metabolism and Environment on Neuropsychiatric Disorders. Current Reviews in Clinical and Experimental Pharmacology 2025; 20(4) doi: 10.2174/0127724328335219241202142003
|
| 106 |
|
| 107 |
Irina-Florina Ivan, Valentina-Laura Irincu, Ștefania Diaconu, Oana Falup‑Pecurariu, Bogdan Ciopleiaș, Cristian Falup‑Pecurariu. Gastro‑intestinal dysfunctions in Parkinson's disease (Review). Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10517
|
| 108 |
Jolien Schol, Lucas Wauters, Ram Dickman, Vasile Drug, Agata Mulak, Jordi Serra, Paul Enck, Jan Tack. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. Neurogastroenterology & Motility 2021; 33(8) doi: 10.1111/nmo.14237
|
| 109 |
Zhikun Sun, Xingrong Ma, Hongqi Yang, Shuai Chen, Shuang He, Ruihua Sun, Hong Lu, Jiewen Zhang. Characterization of Age-dependent Behavior Deficits in the PGC-1α Knockout Mouse, in Relevance to the Parkinson's Disease Model. Neuroscience 2020; 440 doi: 10.1016/j.neuroscience.2020.05.015
|
| 110 |
Klaus W. Lange, Yukiko Nakamura, Ning Chen, Jianjun Guo, Shigehiko Kanaya, Katharina M. Lange, Shiming Li. Diet and medical foods in Parkinson’s disease. Food Science and Human Wellness 2019; 8(2) doi: 10.1016/j.fshw.2019.03.006
|
| 111 |
Kun-Siang Huang, Bo-Lin Pan, Wei-An Lai, Pin-Jie Bin, Yao-Hsu Yang, Chia-Pei Chou, Alexandru Rogobete. Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study. PLOS ONE 2021; 16(4) doi: 10.1371/journal.pone.0249645
|
| 112 |
Zhi-Lan Zhou, Xue-Bing Jia, Meng-Fei Sun, Ying-Li Zhu, Chen-Meng Qiao, Bo-Ping Zhang, Li-Ping Zhao, Qin Yang, Chun Cui, Xue Chen, Yan-Qin Shen. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites. Neurotherapeutics 2019; 16(3) doi: 10.1007/s13311-019-00719-2
|
| 113 |
Maithrayie Kumaresan, Safeera Khan. Spectrum of Non-Motor Symptoms in Parkinson's Disease . Cureus 2021; doi: 10.7759/cureus.13275
|
| 114 |
E. Antonen. Non-motor manifestations of Parkinson's disease – constipation. Meditsinskaya sestra 2026; doi: 10.29296/25879979-2026-02-08
|
| 115 |
Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer. Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives. Movement Disorders 2017; 32(1) doi: 10.1002/mds.26866
|
| 116 |
Qian-Qian Chen, Caroline Haikal, Wen Li, Jia-Yi Li. Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease. Frontiers in Molecular Neuroscience 2019; 12 doi: 10.3389/fnmol.2019.00218
|
| 117 |
Martina Montanari, Paola Imbriani, Paola Bonsi, Giuseppina Martella, Antonella Peppe. Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061560
|
| 118 |
Oluwatosin Atewogboye, John Paul Taylor, Judith R. Harrison. Pharmacological strategies for managing dementia with Lewy bodies: an expert review of symptom-targeted care. Expert Review of Clinical Pharmacology 2025; 18(9) doi: 10.1080/17512433.2025.2562151
|
| 119 |
Anna J. Pedrosa Carrasco, Lars Timmermann, David J. Pedrosa. Management of constipation in patients with Parkinson’s disease. npj Parkinson's Disease 2018; 4(1) doi: 10.1038/s41531-018-0042-8
|
| 120 |
Yun Shi, Chen-Meng Qiao, Yu Zhou, Ji Wu, Chun Cui, Hui Hong, Xue-Bing Jia, Shu-Bing Huang, Li Yao, Wei-Jiang Zhao, Yan-Qin Shen. Protective effects of prucalopride in MPTP-induced Parkinson’s disease mice: Neurochemistry, motor function and gut barrier. Biochemical and Biophysical Research Communications 2021; 556 doi: 10.1016/j.bbrc.2021.03.109
|
| 121 |
Maryann N. Krasko, John Szot, Karolina Lungova, Linda M. Rowe, Glen Leverson, Cynthia A. Kelm-Nelson, Michelle R. Ciucci. Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease. Dysphagia 2023; 38(5) doi: 10.1007/s00455-023-10567-0
|
| 122 |
Eamonn M. M. Quigley. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current Neurology and Neuroscience Reports 2017; 17(12) doi: 10.1007/s11910-017-0802-6
|
| 123 |
Shilan Mozaffari, Shekoufeh Nikfar, Marzieh Daniali, Mohammad Abdollahi. The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief. Expert Opinion on Pharmacotherapy 2020; 21(6) doi: 10.1080/14656566.2020.1726319
|
| 124 |
Sarah Vascellari, Vanessa Palmas, Marta Melis, Silvia Pisanu, Roberto Cusano, Paolo Uva, Daniela Perra, Veronica Madau, Marianna Sarchioto, Valentina Oppo, Nicola Simola, Micaela Morelli, Maria Laura Santoru, Luigi Atzori, Maurizio Melis, Giovanni Cossu, Aldo Manzin, Vanni Bucci. Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease. mSystems 2020; 5(5) doi: 10.1128/mSystems.00561-20
|
| 125 |
Norman-Vivaldi Montúffar-Otero, Annel Gómez-Coello, Paulina Murphy, Aisha-Alexandra Murillo-Chavez, Ernesto Roldan-Valadez. Top-Cited Articles on Dysphagia and Cognitive Impairment: A Scopus-Based Bibliometric Analysis of Publications Retrieved Through October 2025. Cureus 2026; doi: 10.7759/cureus.110620
|
| 126 |
Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch. Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats. PLOS ONE 2018; 13(1) doi: 10.1371/journal.pone.0190078
|
| 127 |
Margarita M. Rudenok, Maria I. Shadrina, Elena V. Filatova, Ivan N. Rybolovlev, Maxim S. Nesterov, Denis A. Abaimov, Ruslan A. Ageldinov, Anna A. Kolacheva, Michael V. Ugrumov, Petr A. Slominsky, Anelya Kh. Alieva. Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease. Life 2022; 12(5) doi: 10.3390/life12050751
|
| 128 |
Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, Nicolas Carrière, Romain Viard, Renaud Lopes, Gregory Kuchcinski, Alexandre Eusebio, Stephane Thobois, Elodie Hainque, Cecile Hubsch, Olivier Rascol, Christine Brefel, Sophie Drapier, Caroline Giordana, Franck Durif, David Maltête, Dominique Guehl, Lucie Hopes, Tiphaine Rouaud, Bechir Jarraya, Isabelle Benatru, Christine Tranchant, Melissa Tir, Marie Chupin, Eric Bardinet, Luc Defebvre, Jean-Christophe Corvol, David Devos. Can Dopamine Responsiveness Be Predicted in Parkinson’s Disease Without an Acute Administration Test?. Journal of Parkinson’s Disease 2022; 12(7) doi: 10.3233/JPD-223334
|
| 129 |
C Warren Olanow, Werner Poewe, Olivier Rascol, Fabrizio Stocchi. From OFF to ON—Treating OFF Episodes in Parkinson’s Disease. Neurology 2020; 16(Suppl. 1) doi: 10.17925/USN.2020.16.Suppl.1.2
|
| 130 |
Naveed Malek, Sofia Kanavou, Michael A. Lawton, Vanessa Pitz, Katherine A. Grosset, Nin Bajaj, Roger A. Barker, Yoav Ben-Shlomo, David J. Burn, Tom Foltynie, John Hardy, Nigel M. Williams, Nicholas Wood, Huw R. Morris, Donald G. Grosset. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression. Parkinsonism & Related Disorders 2019; 65 doi: 10.1016/j.parkreldis.2019.05.022
|
| 131 |
Takashi Ogawa, Genko Oyama, Nobutaka Hattori. Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation. BMJ Case Reports 2018; 2018 doi: 10.1136/bcr-2017-223722
|
| 132 |
Laurie K. Mischley. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. International Review of Neurobiology 2017; 134 doi: 10.1016/bs.irn.2017.04.013
|
| 133 |
Ying-Jia Li, Ian-I Leong, Jing-Qi Fan, Ming-Yue Yan, Xin Liu, Wei-Jing Lu, Yuan-Yuan Chen, Wei-Qiang Tan, Yu-Ting Wang, Li-Xing Zhuang. Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial. Frontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1126080
|
| 134 |
Artem Minalyan, Lilit Gabrielyan, Claudio Pietra, Yvette Taché, Lixin Wang. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats. Frontiers in Integrative Neuroscience 2019; 13 doi: 10.3389/fnint.2019.00013
|